Josh Mandel-Brehm
Director/Board Member at PROMIS NEUROSCIENCES, INC.
Net worth: - $ as of 29/04/2024
Josh Mandel-Brehm active positions
Companies | Position | Start | End |
---|---|---|---|
PROMIS NEUROSCIENCES, INC. | Director/Board Member | 31/08/2021 | - |
Independent Dir/Board Member | 31/08/2021 | - | |
Camp4 Therapeutics Corp.
Camp4 Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Camp4 Therapeutics Corp. operates as a biotechnology company. The firm discovers a treatment option for patients. The company was founded by Paulina Hill and Leonard Zon on May 20, 2016 and is headquartered in Cambridge, the United Kingdom. | Director/Board Member | 30/04/2017 | - |
Chief Executive Officer | 30/04/2017 | - | |
President | 30/04/2017 | - | |
Vico Therapeutics BV
Vico Therapeutics BV BiotechnologyHealth Technology Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022. | Director/Board Member | 31/08/2019 | - |
Founder | 31/08/2019 | - |
Career history of Josh Mandel-Brehm
Training of Josh Mandel-Brehm
University of Michigan | Masters Business Admin |
Washington University in St. Louis | Undergraduate Degree |
Statistics
International
United States | 4 |
Netherlands | 2 |
Canada | 2 |
Operational
Director/Board Member | 3 |
Chief Executive Officer | 1 |
President | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
PROMIS NEUROSCIENCES, INC. | Health Technology |
Private companies | 2 |
---|---|
Camp4 Therapeutics Corp.
Camp4 Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Camp4 Therapeutics Corp. operates as a biotechnology company. The firm discovers a treatment option for patients. The company was founded by Paulina Hill and Leonard Zon on May 20, 2016 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Vico Therapeutics BV
Vico Therapeutics BV BiotechnologyHealth Technology Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022. | Health Technology |
- Stock Market
- Insiders
- Josh Mandel-Brehm
- Experience